| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.0M | +5.2% | -27.1% |
| R&D Expense | $2.6M | -10.8% | -36.4% |
| SG&A Expense | $8.6M | -2.1% | -5.6% |
| Operating Income | -$6.3M | +11.3% | -62.1% |
| Interest Expense | $711K | +1.3% | -44.5% |
| Pre-tax Income | -$7.6M | -3.2% | +5.2% |
| Income Tax | -$12K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.2M | +87.6% | +40.4% |
| Accounts Receivable | $32.1M | +2.9% | -39.0% |
| Current Assets | $49.5M | +5.5% | -25.2% |
| Total Assets | $76.1M | +2.1% | -20.7% |
| Current Liabilities | $48.4M | -2.5% | -31.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | — |
| Capital Expenditures | $48K | — | — |
| Investing Cash Flow | -$4.9M | — | — |
| Financing Cash Flow | $8.4M | — | — |
| Free Cash Flow | -$4.3M | — | — |
| +88.8% |
| +65.7% |
| Net Income | -$7.6M | -4.6% | +4.9% |
| EPS (Basic) | -$0.27 | +10.0% | +43.7% |
| EPS (Diluted) | -$0.27 | +10.0% | +43.7% |
| $26.0M |
| +12.3% |
| -31.4% |
| Total Liabilities | $54.5M | -1.6% | -28.3% |
| Stockholders' Equity | $21.6M | +12.9% | +8.0% |